Position in ABT
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$9,436
-$36,046 QoQ
Shares Held
104
-76.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2,907
of 2,968 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Hurley Capital, LLC holds $125,211 across 11 Medical Devices names. ABT ranks #3 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PEN |
Penumbra Inc
|
230 | $72,622 | |
| 2 | BSX |
Boston Scientific Corp
|
445 | $18,992 | |
| 3 | ABT |
Abbott Laboratories
This page
|
104 | $9,436 | |
| 4 | NVCR |
NovoCure Ltd
|
397 | $6,014 | |
| 5 | CLPT |
ClearPoint Neuro, Inc.
|
330 | $5,887 | |
| 6 | PACB |
Pacific Biosciences Of California, Inc.
|
2,976 | $4,999 | |
| 7 | ZBH |
Zimmer Biomet Holdings, Inc.
|
48 | $4,132 | |
| 8 | NNOX |
Nano-X Imaging Ltd.
|
1,133 | $1,314 |
All Filings in ABT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,436 | 104 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $45,482 | 443 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $55,002 | 439 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $59,871 | 447 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $59,300 | 436 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $57,570 | 434 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $60,853 | 538 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||